Go Deep
DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,845 | -10.9 | 11.00 | 0.01 | 744.73 |
| Oct 2026 | 16,035 | -10.6 | 10.77 | 0.01 | 727.30 |
| Oct 2026 | 15,584 | -11.5 | 11.31 | 0.01 | 763.49 |
| Oct 2026 | 16,141 | -10.5 | 10.65 | 0.01 | 716.99 |
| Oct 2026 | 15,786 | -10.9 | 11.07 | 0.01 | 746.20 |
| Oct 2026 | 14,838 | -12.0 | 12.20 | 0.01 | 822.06 |
| Oct 2026 | 14,814 | -12.1 | 12.22 | 0.01 | 821.92 |
| Oct 2026 | 14,886 | -12.0 | 12.14 | 0.01 | 814.59 |
DiaMedica Therapeutics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -10,139,000.0 | -10,042,000.0 | -8,740,000.0 | -8,620,000.0 |
| EPS | -0.2 | -0.2 | — | -0.2 |
DiaMedica Therapeutics Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -32,766,000.0 | -24,444,000.0 | -19,381,000.0 | -13,676,000.0 |
| EPS | -0.7 | -0.6 | -0.6 | -0.5 |
DiaMedica Therapeutics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 61,371,000.0 | 46,345,000.0 | 54,160,000.0 | 34,395,000.0 | — |
| Total Liabilities | 5,260,000.0 | 5,627,000.0 | 3,103,000.0 | 2,568,000.0 | — |
| Total Equity | 56,111,000.0 | 40,718,000.0 | 51,057,000.0 | 31,827,000.0 | — |
Owes vs Owns
DiaMedica Therapeutics Inc. owed $0.15 for every $1 it owned in Jun 2026, up from $0.07 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.15× | 0.09× | 0.12× | 0.06× | 0.07× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
DiaMedica Therapeutics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 97.6%Fixed assets (tangible) 0.6%Other assets 1.4%
How it's funded — Dec 2025
Payables 2.4%Other liabilities 5.8%Shareholders' equity 91.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 59.9 | 44.1 | 52.9 | 33.5 |
| Receivables | 0.3 | 0.2 | 0.4 | 0.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.3 | 0.4 | 0.5 | 0.6 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.9 | 1.5 | 0.4 | 0.3 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term debt | 0.1 | 0.2 | 0.3 | 0.4 |
| Payables | 1.5 | 0.9 | 0.9 | 0.7 |
| Other liabilities | 3.5 | 4.3 | 1.8 | 1.4 |
| Shareholders' equity | 56.1 | 40.7 | 51.1 | 31.8 |
| Net tangible assets | 56.1 | 40.7 | 51.1 | 31.8 |
DiaMedica Therapeutics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -29,062,000.0 | -22,076,000.0 | -18,728,000.0 | -11,511,000.0 | — |
| Investing Activities | -2,192,000.0 | 8,564,000.0 | -18,299,000.0 | 11,538,000.0 | — |
| Financing Activities | 43,876,000.0 | 11,994,000.0 | 36,842,000.0 | -6,000.0 | — |